epidermolysis bullosa simplex |
Disease ID | 68 |
---|---|
Disease | epidermolysis bullosa simplex |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:14) HP:0002664 | Neoplasm HP:0001000 | Abnormality of skin pigmentation HP:0008391 | Dystrophic fingernails HP:0000982 | Palmoplantar keratoderma HP:0001597 | Abnormality of the nail HP:0001810 | Dystrophic toenail HP:0002021 | Pyloric stenosis HP:0001531 | Failure to thrive in infancy HP:0008386 | Aplasia/Hypoplasia of the nails HP:0001231 | Abnormality of the fingernails HP:0200042 | Skin ulcer HP:0008066 | Abnormal blistering of the skin HP:0000962 | Hyperkeratosis HP:0000987 | Atypical scarring of skin |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:12) HP:0003560 | Muscular dystrophy | 15 HP:0001070 | Mottled pigmentation | 9 HP:0001638 | Cardiomyopathy | 2 HP:0007081 | Late-onset muscular dystrophy | 1 HP:0010783 | Erythema | 1 HP:0000508 | Drooping upper eyelid | 1 HP:0001644 | Congestive cardiomyopathy | 1 HP:0000602 | Ophthalmoplegia | 1 HP:0002224 | Woolly hair | 1 HP:0200037 | Skin vesicle | 1 HP:0011664 | Left ventricular non-compaction cardiomyopathy | 1 HP:0001010 | Hypopigmentation of the skin | 1 |
Disease ID | 68 |
---|---|
Disease | epidermolysis bullosa simplex |
Manually Symptom | UMLS | Name(Total Manually Symptoms:3) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:18) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs11170164 | 20849457 | 3852 | KRT5 | umls:C0079298 | BeFree | A transient epidermolysis bullosa simplex-like phenotype associated with bexarotene treatment in a G138E KRT5 heterozygote. | 0.15418532 | 2010 | KRT5 | 12 | 52519884 | C | T |
rs267607392 | 20030639 | 3861 | KRT14 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.151003963 | 2010 | KRT14 | 17 | 41586428 | A | T,G |
rs267607392 | 20030639 | 3852 | KRT5 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.15418532 | 2010 | KRT14 | 17 | 41586428 | A | T,G |
rs267607396 | 20030639 | 3861 | KRT14 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.151003963 | 2010 | KRT14 | 17 | 41586453 | A | G |
rs267607396 | 20030639 | 3852 | KRT5 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.15418532 | 2010 | KRT14 | 17 | 41586453 | A | G |
rs267607412 | 15102078 | 3872 | KRT17 | umls:C0079298 | BeFree | This mutation predicts the substitution of asparagine by aspartic acid in codon 109 (N109D) located in the second half of the keratin 17 1A domain, where similar mutation in keratin 5 is associated with the mild Weber-Cockayne form of epidermolysis bullosa simplex. | 0.000271442 | 2004 | KRT17 | 17 | 41624185 | T | C |
rs267607412 | 15102078 | 3852 | KRT5 | umls:C0079298 | BeFree | This mutation predicts the substitution of asparagine by aspartic acid in codon 109 (N109D) located in the second half of the keratin 17 1A domain, where similar mutation in keratin 5 is associated with the mild Weber-Cockayne form of epidermolysis bullosa simplex. | 0.15418532 | 2004 | KRT17 | 17 | 41624185 | T | C |
rs267607435 | 19220453 | 3852 | KRT5 | umls:C0079298 | BeFree | A novel mutation (p.Thr198Ser) in the 1A helix of keratin 5 causes the localized variant of epidermolysis bullosa simplex. | 0.15418532 | 2009 | KRT5 | 12 | 52519123 | G | C |
rs57364972 | 10733662 | 3861 | KRT14 | umls:C0079298 | BeFree | In this way, three novel mutations could be identified, Y415H, L419Q, and E422K, all located in the helix termination motif of the keratin 14 rod domain 2B, resulting in moderate, severe, and mild epidermolysis bullosa simplex phenotype, respectively. | 0.151003963 | 2000 | KRT14 | 17 | 41583253 | A | T |
rs58380626 | 10733662 | 3861 | KRT14 | umls:C0079298 | BeFree | In this way, three novel mutations could be identified, Y415H, L419Q, and E422K, all located in the helix termination motif of the keratin 14 rod domain 2B, resulting in moderate, severe, and mild epidermolysis bullosa simplex phenotype, respectively. | 0.151003963 | 2000 | KRT14 | 17 | 41583266 | A | G |
rs58762773 | 10733662 | 3861 | KRT14 | umls:C0079298 | BeFree | In this way, three novel mutations could be identified, Y415H, L419Q, and E422K, all located in the helix termination motif of the keratin 14 rod domain 2B, resulting in moderate, severe, and mild epidermolysis bullosa simplex phenotype, respectively. | 0.151003963 | 2000 | KRT14 | 17 | 41583245 | C | T |
rs58766676 | 14723728 | 3852 | KRT5 | umls:C0079298 | BeFree | A new keratin 5 mutation (K199T) in a family with Weber-Cockayne epidermolysis bullosa simplex. | 0.15418532 | 2004 | KRT5 | 12 | 52519120 | T | G,C,A |
rs59464425 | 10782015 | 3852 | KRT5 | umls:C0079298 | BeFree | K5 D328E: a novel missense mutation in the linker 12 domain of keratin 5 associated with epidermolysis bullosa simplex (Weber-Cockayne). | 0.15418532 | 2000 | KRT5 | 12 | 52517698 | G | T |
rs59851104 | 20030639 | 3852 | KRT5 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.15418532 | 2010 | KRT5 | 12 | 52519869 | A | T,G |
rs59851104 | 20030639 | 3861 | KRT14 | umls:C0079298 | BeFree | Novel mutations were found in two patients with the EBS-Dowling-Meara variant (EBS-DM) [KRT14-p.Ser128Pro and KRT14-p.Gln374_Leu387dup(14)] and in three patients with localized EBS (KRT14-p.Leu136Pro and KRT5-p.Val143Ala). | 0.151003963 | 2010 | KRT5 | 12 | 52519869 | A | T,G |
rs60399023 | 25830653 | 3861 | KRT14 | umls:C0079298 | BeFree | Co-expression of K5 and a K14(R125C) mutant that causes the most severe form of EBS resulted in widespread formation of EBS-like cytoplasmic keratin aggregates in epithelial and non-epithelial fly tissues. | 0.151003963 | 2015 | KRT14 | 17 | 41586462 | G | C,A |
rs60399023 | 25830653 | 3852 | KRT5 | umls:C0079298 | BeFree | Co-expression of K5 and a K14(R125C) mutant that causes the most severe form of EBS resulted in widespread formation of EBS-like cytoplasmic keratin aggregates in epithelial and non-epithelial fly tissues. | 0.15418532 | 2015 | KRT14 | 17 | 41586462 | G | C,A |
rs60399023 | 21967011 | 3861 | KRT14 | umls:C0079298 | BeFree | Atypical epidermolysis bullosa simplex with a missense keratin 14 mutation p.Arg125Cys. | 0.151003963 | 2011 | KRT14 | 17 | 41586462 | G | C,A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001000 | Abnormality of skin pigmentation | MP:0002075 | abnormal coat/hair pigmentation;HP:0001231 | Abnormality of the fingernails |
Mapped by homologous gene(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002664 | Neoplasm | MP:0005402 | abnormal action potential;HP:0200042 | Skin ulcer |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |